KRAS and lung carcinoma: It is known that Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation is one of the most common genetic alterations involved in lung cancer [33] and is associated with reduced response to IGF1R-targeted therapy in lung cancer cells [34].